Publications

Eagle IP Recognized as Top Tier Firm (Tier 1) for Patent Prosecution in IP Stars 2024 Patent Firms Ranking List July, 2024 Dear friends and colleagues, We are proud to announce that Eagle IP has been ranked Tier 1 (the highest tier) for Patent Prosecution in the IP Stars 2024 Patent Firms Ranking List published

Beijing IP Court Reverses CNIPA’s decision, accepting Novo Nordisk’s Post Filing Data and Ultimately Maintaining the Semaglutide “Ozempic” patent as VALID June, 2024 Recently, all eyes have been on China as the fundamental patent covering semaglutide, the active ingredient in Ozempic and Wegovy, will expire on March 20, 2026. It goes without saying that generics

A More Detailed Overview of China’s Patent Term Extension (PTE) System June, 2024 Although PTE has been in the Chinese Patent Law since the 4th Amendment of the law came into effect June 1, 2021, we didn’t really know the exact details of how it operated until the Implementation Regulations and Examination Guidelines (“Implementation Regulations”)

Jennifer Che and Yolanda Wang Ranked Among Leading Patent Individuals in IAM Patent 1000 for 2024 June, 2024 Dear friends and colleagues, We are delighted to announce that our President and Managing Director, Ms. Jennifer Che, and Principal, Ms. Yolanda Wang have been named in this year's list of Leading Patent Individuals in the Hong

Dr. Jacqueline Lui and Ms. Pauli Wong Named Patent Star 2024 by Managing IP June, 2024 Dear friends and colleagues, We are proud to announce that two members of our team, Founder and Director, Dr. Jacqueline Lui, and Principal, Ms. Pauli Wong, have been recognized as Patent Star 2024 by Managing IP. This prestigious award

Eagle IP Ranked Among Top Tier Firms in IAM Patent 1000 June, 2024 Dear friends and colleagues, We are delighted to announce that Eagle IP has been recognized once more as a Highly Recommended Firm in Patent Prosecution by IAM Patent 1000 for 2024. IAM has highlighted Eagle IP as a highly sought-after firm for

Everything you need to know about Patent Term Adjustment (PTA) in China May, 2024 We previously discussed patent term compensation for patent office delay ('Patent Term Adjustment' or 'PTA') when such new system was introduced in the Fourth Amendment of the Chinese Patent Law (2020), as well as in the different versions of the Draft

Stay Ahead: Getting a Chinese Patent in Three Months? April, 2024 The China National Intellectual Property Administration (CNIPA) has announced a significant development in the realm of patent prosecution: the initiation of the "PPH Improvement Initiative" in collaboration with key patent offices from the United States, Europe, Japan, and South Korea. This initiative aims to

Miss the 12-month Filing Deadline? China Finally Allows Patent Applicants to Restore, Add, or Correct a Priority Claim April, 2024 Three major 'remedial' systems taken from the PCT Regulations have been introduced in the third revision of the Implementation Regulations of the Chinese Patent Law in 2023 (hereinafter referred to as the "Implementation Regulations"). We

New Remedy in China for Fixing "Errors" in a Patent Application: Incorporation by Reference March, 2024   Background As mentioned in our earlier article, the Implementation Regulations of the Chinese Patent Law ("Regulations", similar to the CFR in the US) were approved in November, and the CNIPA finally made public the full text of the Regulations just